Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - ImmunoGen, Inc. | imgn-20210630x10q.htm |
| EX-31.2 - EX-31.2 - ImmunoGen, Inc. | imgn-20210630xex31d2.htm |
| EX-31.1 - EX-31.1 - ImmunoGen, Inc. | imgn-20210630xex31d1.htm |
EXHIBIT 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report for the period ended June 30, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: July 30, 2021 | /s/ MARK J. ENYEDY |
| Mark J. Enyedy |
| President, Chief Executive Officer |
| (Principal Executive Officer) |
| |
Dated: July 30, 2021 | /s/ SUSAN ALTSCHULLER Ph.D. |
| Susan Altschuller Ph.D. |
| Senior Vice President, Chief Financial Officer |
| (Principal Financial Officer) |
| |
| |
| |
| |